Sugar Maple Asset Management’s Transmedics TMDX Stock Holding History

Sugar Maple Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$298K	Hold	3,000	–	–	0.18%	71
2025 Q4	$365K	Hold	3,000	–	–	0.25%	61
2025 Q3	$337K	Sell	3,000 -1,000	-25%	-$117K	0.24%	63
2025 Q2	$536K	Sell	4,000 -7,000	-64%	-$769K	0.42%	41
2025 Q1	$740K	Buy	+11,000	New	+$757K	0.58%	33

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sugar Maple Asset Management's TMDX Position: Q1 2026 in Review

Sugar Maple Asset Management held its Transmedics (TMDX) position steady in Q1 2026 at 3,000 shares worth $298K. The position accounts for 0.18% of the portfolio, ranked #71.

Sugar Maple Asset Management first reported a position in TMDX in Q1 2025 and has held it in 5 quarters since. The position peaked at $740K in Q1 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Sugar Maple Asset Management held 3,000 shares of Transmedics worth $298K as of Q1 2026.
Sugar Maple Asset Management left its Transmedics share count unchanged in Q1 2026.
Transmedics made up 0.18% of Sugar Maple Asset Management's portfolio in Q1 2026, its #71 holding.
Sugar Maple Asset Management first reported a position in Transmedics in Q1 2025 and has held it in 5 quarters since.
Sugar Maple Asset Management's Transmedics position peaked at $740K in Q1 2025.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Sugar Maple Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.